Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Q1 2013 Bookings Update

18 Apr 2013 07:00

RNS Number : 6292C
WANdisco Plc
18 April 2013
 



 

 

 

18 April 2013

WANdisco plc

Q1 2013 Bookings Update

Q1 subscription bookings increase by 96 per cent year-on-year

Renewal rate 134 per cent

 

Sheffield, UK - WANdisco (LSE: WAND), a provider of high-availability software for global enterprises to meet the challenges of Big Data and distributed software development, is pleased to provide the following update for the three months ended 31 March 2013.

 

In the first quarter of the new financial year, subscription bookings reached a record level of $3.035 million, representing a 96 per cent increase year-on-year (2012: $1.545 million).

 

Notable new customers signed in the first quarter included General Atomics, FutureWei (a division of Huawei), Société Générale and Maxim. In addition, the Company saw significant growth in existing customer accounts including Home Depot, Nokia, John Deere and McAfee all of whom expanded their use of WANdisco products within their organisations.

 

The annualised renewal rate by booking value was 134 per cent. Renewals included Sony, McGraw Hill, Raytheon, Vanguard, Borg Gais and Blue Shield. When one particularly large increased renewal is excluded the underlying rate of renewal is 117 per cent.

 

During the period the Company announced the release of its new products for the fast growing Hadoop Big Data market. Hadoop is a proven, open source Big Data technology which serves as the backbone for many of the world's largest and most important databases utilised by companies such as Yahoo, Facebook, Netflix, Amazon and eBay. According to the analyst firm Wikibon, the market for solutions able to solve Big Data issues is forecast to grow at a compound annual rate of 58% between 2012 and 2017 from $5 billion to over $50 billion.

 

WANdisco's flagship Big Data product, the Non-Stop NameNode, is the only 100 per cent uptime solution for Hadoop. Built on the company's Non-Stop patented replication technology, Non-Stop NameNode completely eliminates the single point of failure that risks data availability - the NameNode - which tracks the location of data within a Hadoop cluster and coordinates client access to it.

 

The Company also filed three new additional patents related to distributed computing with applications in the Big Data market to complement the patent awarded by the US Patent and Trademark Office (USPTO) for its core replication technology in November last year.

 

WANdisco will report results for the financial year ended 31 December 2012 on Thursday, 25 April 2013.

 

Ends

 

For further information please contact:

 

WANdisco plc:

David Richards, Chairman and Chief Executive Officer

via FTI Consulting

Nick Parker, Chief Financial Officer

FTI Consulting:

+44 (0)20 7831 3113

Matt Dixon / Sophie McMillan / Jon Snowball

Panmure Gordon & Co.

+44 (0)20 7886 2500

Fred Walsh / Grishma Patel (Corporate Finance)

Adam Pollock, Charles Leigh-Pemberton, Ben Roberts (Investment Banking)

 

 

About WANdisco plc

 

WANdisco (LSE: WAND) is a provider of enterprise-ready, high-availability software solutions that enable globally distributed organizations to meet today's data challenges of secure storage, scalability and availability. WANdisco's products are differentiated by the company's patented, active/active data replication technology, serving crucial high availability (HA) requirements, including Hadoop Big Data and Application Lifecycle Management (ALM). Fortune Global 1000 companies including AT&T, Motorola, Intel and Halliburton rely on WANdisco for performance, reliability, security and availability. For additional information, please visit www.wandisco.com.

 

Product and company names herein may be trademarks of their registered owners.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBDLLFXZFZBBV
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.